Imperial College London Diabetes Centre and Hammersmith Medicine Host Key Continued Medical Education For Doctors In April
MRCP 1 and MRCP 2 April 1-3 2012 www.icldc.co.uk
Abu Dhabi: Doctors region-wide still have the chance to participate in two, world-recognised medical courses at Imperial College London Diabetes Centre, Abu Dhabi next month (April 2012), according to Hammersmith Medicine's, Professor Karim Meeran.
He said that interest for the two coveted MRCP courses (Membership of the Royal College of Physicians) is high but that there is still a chance for medical practitioners to register.
The two programmes, MRCP 1 and MRCP 2, are scheduled to take place at ICLDC's Lecture Theatre for three days, starting April 1. Both courses are endorsed with 21 hours of HAAD-accredited Continued Medical Education (CME).
The programmes will be presented by Professor Meeran, along with Dr John Chambers and Dr Amir Sam. All three doctors are specialists with Imperial College London.
Previous courses held at ICLDC have received positive feedback, with one delegate saying that it was the one of the best courses experienced in three decades. Another endorsement noted that the most complex of topics were very well explained.
Professor Meeran said that one of the key hurdles for doctors-in-training is passing the MRCP exam. "We want to give full support to doctors and from this year we plan to host MRCP 1 and 2 three times a year in Abu Dhabi to complement the exam timings."
The MRCP 1 and MRCP 2 courses from Hammersmith Medicine will be held at ICLDC on April 1-3 2012, August 12-14 2012 and on November 18-20 2012. Registration can be made online at www.icldc.co.uk or at cme@icldc.ae or Tel: + 971 2 404 0870
-Ends-
About Imperial College London Diabetes Centre
Imperial College London Diabetes Centre is a one-stop, state-of-the-art, out-patient facility that specialises in diabetes treatment, research, training and public health awareness, with two centres - one each in Abu Dhabi and Al Ain.
The purpose-built centres are an initiative of Mubadala Healthcare, in partnership with the UK's Imperial College London. Mubadala Healthcare, a division of Mubadala Development Company, is specifically dedicated to investment in strategic, high value and economically sustainable projects that meaningfully enhance the private healthcare infrastructure of Abu Dhabi and the UAE.
The launch of ICLDC in 2006 is testament to the vision of Mubadala Healthcare to develop projects that protect and enhance the nation's health. ICLDC has offered diabetes prevention, education and treatment to more than 100,000 people.
'Diabetes-Knowledge-Action' is ICLDC's award-winning public health awareness campaign. It was launched in 2007 under the patronage of HH Sheikha Fatima bint Mubarak, in partnership with The Emirates Foundation for Philanthropy.
ICLDC Abu Dhabi holds the Joint Commission International (JCI) Clinical Care Program Certification (CCPC) in Diabetes Management and JCI Accreditation for Ambulatory Care. When the Centre received the awards it became the only healthcare provider worldwide to hold both certifications and the first facility in the Middle East and third globally to hold JCI's highly-acclaimed CCPC specifically for the clinical management of diabetes.
For media enquiries:
Susan Furness at Strategic Solutions for ICLDC
Tel.: + 9714 3903030,
Mobile: + 97150 6556126
Email: susan@strategicsolutionsonline.com
© Press Release 2012
